Meet the BBI Solutions Leadership Team
Group Chief Executive Officer
With more than 25 of years international experience in the diagnostics industry, Mario has a wealth of commercial, technical and operational expertise.
He spent twenty years with Thermo-Fisher Scientific in various operational and commercial roles, most recently as a Division President responsible for 14 manufacturing sites and 30 commercial offices globally.
He has a PhD in Microbiology and Immunodiagnostics and an MBA.
Chief Financial Officer
Richard has over 20 years’ experience working in finance roles within FTSE 250 companies. These include holding senior roles in PWC, Serco and most recently Mitie.
Richard spent nearly 10 years at Mitie as Finance Director, and most recently as Divisional Managing Director where he led a £400M business.
Chief Operations Officer
Ian joined BBI in June 2018.
Previously working in a global role for Johnson & Johnson, Ian has 30 years’ experience global operations, covering manufacturing, planning, quality and supply chain management.
Ian has worked in key roles in Australia and Switzerland. He has a Biochemistry degree from Cardiff University and a master’s degree in Lean Operations from the University of Wales Business School.
Global Head of Quality
Damian is an experienced Quality Director with a career spanning 10 years in pharmaceuticals and Medical Devices.
Prior to joining BBI Damian held various Global Leadership roles in GE Healthcare; latterly heading QARA for the Cell Therapy, Healthcare IT platforms and Consumables divisions.
He is a Chemistry Graduate and Six Sigma black belt with experience in major acquisitions and integrations.
PMO & Performance Director
Having joined BBI in 2019, Mat brings over 20 years’ experience in UK & international finance, commercial and change management roles across both large-scale organisations and SME’s, including KPMG and Mitie.
Mat’s previous roles have seen him lead and deliver significant business change, including in M&A, business re-structuring, process improvement and cost management, outsourcing and systems implementations, as well as leading large cross functional teams.
The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.
Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.
Novarum™ technology transforms a smartphone into a diagnostic test reader, empowering users to read and share the results of rapid tests from the point of care. Our pioneering technology can be used by anyone, anywhere, with minimal training: connecting patients and doctors, field workers, lab researchers and primary care clinicians to specialist practices as part of a mobile eco-system.